SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024486
Filing Date
2022-11-10
Accepted
2022-11-10 16:17:27
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-20220930.htm   iXBRL 10-Q 3064925
2 EX-10.1 kzr-ex10_1.htm EX-10.1 250197
3 EX-31.1 kzr-ex31_1.htm EX-31.1 22177
4 EX-31.2 kzr-ex31_2.htm EX-31.2 22178
5 EX-32.1 kzr-ex32_1.htm EX-32.1 13381
6 GRAPHIC img38315470_0.jpg GRAPHIC 91946
  Complete submission text file 0000950170-22-024486.txt   10546310

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kzr-20220930_pre.xml EX-101.PRE 310930
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kzr-20220930_lab.xml EX-101.LAB 419931
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kzr-20220930.xsd EX-101.SCH 52950
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kzr-20220930_cal.xml EX-101.CAL 46026
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kzr-20220930_def.xml EX-101.DEF 162745
66 EXTRACTED XBRL INSTANCE DOCUMENT kzr-20220930_htm.xml XML 2086651
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 221377472
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences